Herpes zoster risk factors: Difference between revisions

Jump to navigation Jump to search
Line 19: Line 19:
:**Malignancy, especially leukemia and lymphoma
:**Malignancy, especially leukemia and lymphoma
:**HIV<ref name="pmid8728488">{{cite journal| author=Chronister CL| title=Review of external ocular disease associated with aids and HIV infection. | journal=Optom Vis Sci | year= 1996 | volume= 73 | issue= 4 | pages= 225-30 | pmid=8728488 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8728488  }} </ref>
:**HIV<ref name="pmid8728488">{{cite journal| author=Chronister CL| title=Review of external ocular disease associated with aids and HIV infection. | journal=Optom Vis Sci | year= 1996 | volume= 73 | issue= 4 | pages= 225-30 | pmid=8728488 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8728488  }} </ref>
:**Organ transplant (bone marrow or solid organ transplant)
:**Organ transplant (bone marrow or solid organ transplant)<ref name="pmid14267505">{{cite journal| author=HOPE-SIMPSON RE| title=THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. | journal=Proc R Soc Med | year= 1965 | volume= 58 | issue=  | pages= 9-20 | pmid=14267505 | doi= | pmc=1898279 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14267505  }} </ref>
:**Medications ( steroids, chemotherapy or transplant related immunosupression medications)<ref name="pmid12654381">{{cite journal| author=Benz MS, Glaser JS, Davis JL| title=Progressive outer retinal necrosis in immunocompetent patients treated initially for optic neuropathy with systemic corticosteroids. | journal=Am J Ophthalmol | year= 2003 | volume= 135 | issue= 4 | pages= 551-3 | pmid=12654381 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12654381  }} </ref><ref name="pmid19350185">{{cite journal| author=Fernandes NF, Malliah R, Stitik TP, Rozdeba P, Lambert WC, Schwartz RA| title=Herpes zoster following intra-articular corticosteroid injection. | journal=Acta Dermatovenerol Alp Pannonica Adriat | year= 2009 | volume= 18 | issue= 1 | pages= 28-30 | pmid=19350185 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19350185  }} </ref>
:**Medications ( steroids, chemotherapy or transplant related immunosupression medications)<ref name="pmid12654381">{{cite journal| author=Benz MS, Glaser JS, Davis JL| title=Progressive outer retinal necrosis in immunocompetent patients treated initially for optic neuropathy with systemic corticosteroids. | journal=Am J Ophthalmol | year= 2003 | volume= 135 | issue= 4 | pages= 551-3 | pmid=12654381 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12654381  }} </ref><ref name="pmid19350185">{{cite journal| author=Fernandes NF, Malliah R, Stitik TP, Rozdeba P, Lambert WC, Schwartz RA| title=Herpes zoster following intra-articular corticosteroid injection. | journal=Acta Dermatovenerol Alp Pannonica Adriat | year= 2009 | volume= 18 | issue= 1 | pages= 28-30 | pmid=19350185 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19350185  }} </ref>
*Stress
*Stress

Revision as of 14:25, 24 October 2016

Herpes zoster Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Herpes zoster from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Herpes Zoster
Congenital Varicella Syndrome

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Herpes zoster risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Herpes zoster risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Herpes zoster risk factors

CDC on Herpes zoster risk factors

Herpes zoster risk factors in the news

Blogs on Herpes zoster risk factors

Directions to Hospitals Treating Herpes zoster

Risk calculators and risk factors for Herpes zoster risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; L. Katie Morrison, MD;Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Yamuna Kondapally, M.B.B.S[3]

Overview

Risk Factors

  • Shingels are developed in patients who were previously infected with VZV (through natural infection that caused varicella or varicella vaccination).[1]
  • All older adults in the United States are at risk for herpes zoster as approximately 99.5% of people born in the United States who are 40 years of age and older have had varicella.[2]

Risk factors include:

  • Previous varicella virus infection
  • Varicella vaccination
  • Decline in cell mediated immunity[3]
  • Increasing age >50 yrs[4][5]
  • Immunosupression[6][7]
    • Malignancy, especially leukemia and lymphoma
    • HIV[8]
    • Organ transplant (bone marrow or solid organ transplant)[7]
    • Medications ( steroids, chemotherapy or transplant related immunosupression medications)[9][10]
  • Stress

Other potential risk factors include:

  • Women > men[11][12]
  • Whites > African Americans (by at least 50%) [13].

References

  1. CDC http://www.cdc.gov/shingles/hcp/clinical-overview.html (August 2016) Accessed on October 24,2016
  2. Chapman RS, Cross KW, Fleming DM (2003). "The incidence of shingles and its implications for vaccination policy". Vaccine. 21 (19–20): 2541–7. PMID 12744889.
  3. Wung PK, Holbrook JT, Hoffman GS, Tibbs AK, Specks U, Min YI; et al. (2005). "Herpes zoster in immunocompromised patients: incidence, timing, and risk factors". Am J Med. 118 (12): 1416. doi:10.1016/j.amjmed.2005.06.012. PMID 16378799.
  4. Hayward AR, Herberger M (1987). "Lymphocyte responses to varicella zoster virus in the elderly". J Clin Immunol. 7 (2): 174–8. PMID 3033012.
  5. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD; et al. (2005). "A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults". N Engl J Med. 352 (22): 2271–84. doi:10.1056/NEJMoa051016. PMID 15930418. Review in: ACP J Club. 2005 Nov-Dec;143(3):61
  6. Abendroth A, Kinchington PR, Slobedman B (2010). "Varicella zoster virus immune evasion strategies". Curr Top Microbiol Immunol. 342: 155–71. doi:10.1007/82_2010_41. PMC 3936337. PMID 20563710.
  7. 7.0 7.1 HOPE-SIMPSON RE (1965). "THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS". Proc R Soc Med. 58: 9–20. PMC 1898279. PMID 14267505.
  8. Chronister CL (1996). "Review of external ocular disease associated with aids and HIV infection". Optom Vis Sci. 73 (4): 225–30. PMID 8728488.
  9. Benz MS, Glaser JS, Davis JL (2003). "Progressive outer retinal necrosis in immunocompetent patients treated initially for optic neuropathy with systemic corticosteroids". Am J Ophthalmol. 135 (4): 551–3. PMID 12654381.
  10. Fernandes NF, Malliah R, Stitik TP, Rozdeba P, Lambert WC, Schwartz RA (2009). "Herpes zoster following intra-articular corticosteroid injection". Acta Dermatovenerol Alp Pannonica Adriat. 18 (1): 28–30. PMID 19350185.
  11. Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) (2008). "Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR Recomm Rep. 57 (RR-5): 1–30, quiz CE2-4. PMID 18528318.
  12. Thomas SL, Hall AJ (2004). "What does epidemiology tell us about risk factors for herpes zoster?". Lancet Infect Dis. 4 (1): 26–33. PMID 14720565.
  13. Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ (2011). "Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease". JAMA. 305 (2): 160–6. doi:10.1001/jama.2010.1983. PMID 21224457.


Template:WikiDoc Sources